Category: Discrimination

In our piece on what actually happens when someone sues over their weight, two cases ran on the same federal statute and came out opposite ways. A district court in Louisiana held that severe obesity can be a disability under the Americans with Disabilities Act whether or not anything caused it. Four years later the Eighth Circuit held that it cannot, unless something did.

Same law. Different courthouse. Different answer.

That is not a quirk of two cases. It is a map, and until you know where you are standing on it, nothing about the federal route makes sense. So we read every federal appeals court decision on the question in the court’s own text, rather than taking the quotations that these decisions make of each other. Two things came out of that which the standard summary does not contain.

A note on framing before the map. Everything below is the law’s vocabulary, not ours. To use the ADA at all, a fat person has to be re-described as medically impaired, which is a demand the statute makes and we do not endorse. We report what the courts have held. Nothing here is legal advice, and nothing here is a claim about anybody’s health.

The threshold nobody gets past

There is no federal law in the United States that names weight as a protected characteristic. So the only federal door is the ADA, and specifically its “regarded as” prong: it is unlawful to act against someone because of “an actual or perceived physical or mental impairment,” whether or not that impairment limits a major life activity (42 U.S.C. § 12102(3)(A)).

The word that decides everything is impairment. Congress never defined it. The EEOC did, by regulation: a “physical impairment” is “[a]ny physiological disorder or condition, cosmetic disfigurement, or anatomical loss affecting one or more body systems” (29 C.F.R. § 1630.2(h)(1)).

So the fight is over four words. Does being fat count as a “physiological disorder or condition” by itself, or does it only count when some other physiological disorder produced it? If the second, then a fat person in good health is outside the statute, and a fat person who is unwell is inside it. Honesty about your own body becomes the thing that loses the case.

The map

Four circuits have held that a physiological cause is required.

The Second Circuit, in Francis v City of Meriden, No. 1663, Docket 96-9610, decided 17 November 1997: “obesity, except in special cases where the obesity relates to a physiological disorder, is not a ‘physical impairment’ within the meaning of the statutes.”

The Sixth Circuit, in Andrews v Ohio (1997) and then EEOC v Watkins Motor Lines, No. 05-3218, decided 12 September 2006: “to constitute an ADA impairment, a person’s obesity, even morbid obesity, must be the result of a physiological condition.”

The Eighth Circuit, in Morriss v BNSF Railway Co., No. 14-3858, decided 5 April 2016, holding that this survived the 2008 amendments to the ADA because those amendments “did not affect the definition of physical impairment.”

The Seventh Circuit, in Richardson v Chicago Transit Authority, Nos. 17-3508 and 18-2199, decided 12 June 2019: “We join the Second, Sixth, and Eighth Circuits.”

One circuit has an open question, on the record. The Ninth Circuit said so in as many words in Taylor v Burlington Northern Railroad Holdings, No. 16-35205, order of 17 September 2018: “the ADA’s coverage of obesity is an open question in this circuit.” It then certified the state-law version of the question to the Washington Supreme Court, which answered in 2019 that under Washington’s own anti-discrimination law “obesity always qualifies as an impairment” (444 P.3d 606, 608). The Ninth Circuit disposed of the appeal on that state ground in an unpublished memorandum of 30 January 2020, vacating summary judgment and sending the case back. Which means the federal question it flagged is still open today.

One circuit has a plaintiff verdict, under a different statute. Cook v Rhode Island Department of Mental Health, Retardation and Hospitals, First Circuit, decided 22 November 1993, upheld a jury award of $100,000 to a woman who had twice worked the same job with a spotless record, passed the pre-hire physical, and was refused rehire anyway. But Cook was brought under section 504 of the Rehabilitation Act, not the ADA, and it turned on expert testimony at trial that morbid obesity is a physiological disorder. It is not a holding that fatness is covered. It is a holding that this plaintiff proved it was, with witnesses.

Seven circuits have decided nothing. The Third, Fourth, Fifth, Tenth, Eleventh, D.C. and Federal Circuits have no appellate ruling on the question. Not a leaning, not an implied position: nothing. District courts inside them have gone both ways.

The first thing the summaries leave out: the doors are ajar

Every one of the four “no” circuits wrote an escape hatch into its own opinion, and the citation chains between them quietly file the hatches off.

Francis is the clearest. Immediately after the sentence everyone quotes, the Second Circuit added that “a cause of action may lie against an employer who discriminates against an employee on the basis of the perception that the employee is morbidly obese,” citing Cook approvingly. When Morriss cites Francis as agreeing with it, that qualification is not in the quotation.

In Watkins, Judge Gibbons concurred separately to say that “it is possible that morbid obesity is a disorder that by its very nature has a physiological cause,” which “would preclude the need for a plaintiff to put forth evidence that his individual case was caused physiologically.” She rejected the EEOC’s claim only because the agency had offered no evidence for it.

Richardson, the most recent, is the most explicit of all. Its footnote 10: “We need not decide whether, on a particular evidentiary showing, extreme obesity alone can be considered a physiological condition because Richardson presented no such evidence.”

Read together, four courts have said no to the argument as it was actually made to them, and at least three have said they were not deciding the broader question. The rule is narrower than its reputation. What has never been produced in these cases is evidence — and Cook is the one case where it was.

The second thing: it comes down to a comma

Here is the part that is hard to believe until you see the texts side by side.

When the Second Circuit quoted the regulation in 1997, and the Sixth in 2006, it read: “Any physiological disorder, or condition, cosmetic disfigurement, or anatomical loss.” With a comma after disorder. With that comma, “condition” stands on its own, and a condition needs no physiological cause. Without it, “physiological” governs both words, and it does.

That comma was the whole of the plaintiffs’ textual argument for two decades, and Judge Gibbons dismantled it in Watkins by going back to the rulemaking: when the EEOC adopted the definition in 1991 it said it was taking the Rehabilitation Act’s wording, and that wording — at 34 C.F.R. § 104.3 and 45 C.F.R. § 84.3 — has no comma. Neither does the text the EEOC printed in the Federal Register at the time. Her conclusion was that the comma in the published Code of Federal Regulations was a scrivener’s error.

Check the regulation today and the comma is gone. The current text (eCFR, Title 29, current as of 31 August 2026) reads “[a]ny physiological disorder or condition,” and the section’s own source note records exactly one amendment since 1991: 76 FR 16999, 25 March 2011 — the rule implementing the 2008 amendments.

Which produces the irony this whole article is really about. Congress amended the ADA in 2008 to widen it, saying the definition of disability “shall be construed in favor of broad coverage.” The regulation written to carry that out is the one in which the single punctuation mark that fat plaintiffs had been arguing from disappeared. Every court since has read the tidied-up sentence and found it plain.

One honest caveat, because the courts do not agree with each other about their own paperwork. The Ninth Circuit in 2018 dated the comma’s removal to 2009. The Eighth Circuit in 2016 said the only post-amendment change to this definition was the addition of the immune and circulatory body systems, and did not mention the comma at all. Those two accounts cannot both be complete. We tried to settle it in the 2011 rule itself; the Federal Register document ran past what we could retrieve in full, and we are not going to reconstruct the date from secondary sources. So: the comma was there in 2006, it is not there now, the Code records one amendment in between. Checked 3 September 2026.

What the map is actually good for

Not for predicting anything. We are not going to tell you how any circuit would rule, and none of this is advice about a particular case.

What it does show is why the federal detour is a bad road even when it is the only one. Whether the same conduct by the same employer is reachable depends on which of thirteen appellate jurisdictions the courthouse sits in; in seven of them there is no answer at all; and in the four with an answer, the answer turns on a distinction — caused by a disorder, or not — that has nothing to do with whether the employer discriminated.

That is the argument for naming weight in the statute rather than routing it through disability law, and it is the practical difference between the routes we traced in the lawsuits piece: the plaintiff under a city ordinance that lists weight never had to explain her body to anyone. For where weight is actually named in law, see our tracker of weight discrimination laws and the cornerstone on weight discrimination.

Sources: all decisions read in the courts’ own texts. Regulation text and amendment history from the electronic Code of Federal Regulations, checked 3 September 2026.

We have written six pieces about weight discrimination bills: which ones exist, which ones are stuck, which ones died in committee. Not one about what happens after somebody actually files.

That gap matters, because a bill and a case answer different questions. A bill tells you what the law says. A case tells you what the law does. So here are three proceedings, read in the courts’ and the agency’s own documents, each taking a different legal route, each followed to whatever endpoint it reached. Two of them are over. One is not, and that turns out to be the most useful part.

Route one: the city ordinance

Harris v City of New York, Supreme Court, New York County, Index No. 156195/2024, decision of 19 March 2025 (2025 NY Slip Op 25067, Kingo, J.).

Angela Harris passed New York City civil service exam number 3037 for probation officer in 2022 and was placed sixty-third on the list. On 8 May 2024 she appeared for the medical review the city requires, conducted by an NYPD surgeon. According to her amended complaint, she was told at the end of it to “leave and only return after losing 95 LBS,” and was handed a pre-printed form, “NYPD Notice of Medical Review Status PD 407-123,” with a blank line reading “must return to be reweighed after losing ____ LBS.”

She sued on 8 July 2024. Her legal basis is a municipal one: since Local Law 61 of 2023 took effect on 26 November 2023, the New York City Human Rights Law lists height and weight among the protected characteristics, alongside race, religion and the rest. Weight is the protected thing itself. Nobody has to convert it into anything else first.

The city moved to dismiss. On 19 March 2025 the court denied the motion. The reasoning is worth quoting in outline because it is the first of its kind: the court noted that “given the novelty of the law, the pleading standard for weight discrimination under the NYCHRL presents a matter of first impression,” and then borrowed the standard used for the older protected classes. Being told to come back ninety-five pounds lighter, plus a form recording a current weight and a target, was held sufficient to raise an inference of discrimination, and, if substantiated, capable of amounting to direct evidence. The court also let a retaliation claim proceed: the NYPD stopped answering after her lawyer mentioned the lawsuit.

One detail from the opinion’s own footnotes says more about the terrain than the holding does. The city argued she had misled the court by not pleading her weight, and put the number into its own papers to make the point, after she had redacted it from her exhibits. The court’s response was that whether she “would still be considered overweight” is only relevant if weight was a factor in the decision, which was the city’s own position to disprove.

Now the part that gets left out of every summary of this case. Nothing was decided. A denied motion to dismiss means the complaint may proceed; the court said so itself, citing the rule that “whether a plaintiff can ultimately establish its allegations is not part of the calculus.” The same order sent the parties to a settlement conference on 23 April 2025.

What happened after that, we could not establish. Checked on 2 September 2026: no later decision in this case appears in the New York Official Reports, and the state’s public docket portal was behind an access check we do not attempt to get past. So the honest status, twenty-six months after filing, is: open, or resolved quietly. We are not going to guess which.

Route two: the federal detour, and why it usually fails

Morriss v BNSF Railway Co., U.S. Court of Appeals for the Eighth Circuit, No. 14-3858, decided 5 April 2016.

Melvin Morriss applied for a machinist job with BNSF in March 2011 and got a conditional offer, subject to a medical review because the position was safety-sensitive. BNSF had a written rule: no new hires into safety-sensitive positions with a body mass index of 40 or above. Two company examinations put him just over that line, and the offer was withdrawn. The company’s email said he was not qualified “due to significant health and safety risks associated with Class 3 obesity.”

There is no weight provision in federal law, so he sued under the Americans with Disabilities Act, filing in January 2013. That is the detour: to get in the door, you have to argue your body is a disability.

He lost, and the reason is the whole point. The Eighth Circuit held that for obesity to count as a physical impairment under the ADA, “it must result from an underlying physiological disorder or condition.” Morriss had told BNSF on its own questionnaire that his health was good and that he had no limitations; his own doctor confirmed it. Under the court’s reading, that honesty was fatal. The court also rejected the “regarded as” argument with a sentence worth reading twice: the ADA does not prohibit an employer “from acting on its assessment that although no physical impairment currently exists, there is an unacceptable risk of a future physical impairment.” Being refused work over what your body might become one day is, on that reading, lawful.

The Equal Employment Opportunity Commission filed as a friend of the court on Morriss’s side and lost too; the panel held the agency’s litigating position was not entitled to deference. Endpoint: summary judgment for the employer, affirmed. Roughly five years from the withdrawn offer.

Route three: the same detour, a different circuit, and a plaque

EEOC v Resources for Human Development, Inc., No. 2:10-cv-03322, U.S. District Court for the Eastern District of Louisiana.

Lisa Harrison worked as a prevention and intervention specialist at a residential treatment facility for eight years, from 1999 until she was fired in September 2007. The EEOC brought suit in September 2010, charging that she was fired because of her severe obesity although she could do her job.

In December 2011 the district court denied the employer’s summary judgment motions and held the opposite of what the Eighth Circuit would hold four years later: severe obesity is an impairment under the ADA, and it may qualify regardless of whether a physiological disorder caused it. Same federal statute, opposite answer, different courthouse.

A court-approved consent decree was entered on 10 April 2012. The employer paid $125,000, agreed to annual disability-law training for HR staff and corporate directors across its programmes, and to report every disability complaint to the EEOC for three years. It also named a children’s room after Harrison and installed a memorial plaque.

The plaque is not sentiment. It is the endpoint. Harrison died before the EEOC filed the suit. The money went to her estate.

What the three cases add up to

The route decides the case, more than the facts do. Harris did not have to explain her body to anybody; the ordinance names weight, so the argument is about the employer’s conduct. Morriss and Harrison had to be medically re-described before the law would look at them at all, and whether that worked depended on which federal circuit they were in.

The second thing is duration. Filing is the start of a multi-year process, not a result: roughly five years to a final answer for Morriss, four and a half from firing to decree for Harrison, and twenty-six months and counting with no public resolution for Harris.

The third is how new all of this still is. Michigan has listed weight in its civil rights act since 1976. New York City added it in 2023. And in 2025 a court asked how such a claim should be pleaded had to answer it as a matter of first impression, because nobody had written that down yet.

For the current state of the statutes behind these routes, see our reference page on weight discrimination laws, the Washington case where the protection comes from a court and not a legislature, and the cornerstone on weight discrimination.

This is reporting on how three proceedings ran. It is not legal advice, and nothing here is an assessment of anyone’s prospects in any case.

Every list of weight discrimination legislation in the United States uses the same word for the bills that have not passed and have not died: pending. It is one word doing the work of four very different situations. In one chamber a single named person decides whether the bill can move at all. In another, ten signatures on a piece of paper would be enough. In a third, it takes a floor majority of the entire chamber, and only one member is allowed to ask for the vote.

We read the rules of each chamber in the original on 30 August 2026, together with the record of each bill, and wrote down the exit route. This is what “pending” is covering up.

New York: there is no number, only a person

Senate Bill S9803 of the 2025-2026 session was introduced on 6 April 2026 by Senators Sepúlveda, Krueger and Webb and referred that same day to the Committee on Investigations and Government Operations. The bill’s action list on the Senate’s own site has exactly one line in it, the referral. Nothing else has happened.

The Rules of the Senate for 2025-2026 address this situation once, in Rule VI, section 2, on multi-sponsorship. The relevant sentence reads:

The introducer shall at all times retain exclusive control of the bill until formally acted upon by the Senate and any motion to discharge a bill out of committee by a member who is not the introducer of the bill shall be out of order.

There is no signature threshold in that sentence, because there is no petition. There is a person. Senator Sepúlveda is the introducer; Senators Krueger and Webb are multi-sponsors. If either of them moved to discharge S9803 from committee, the motion would be out of order. The number of senators who support the bill is procedurally irrelevant to whether it can leave the committee it is sitting in.

The bill’s own sponsor memorandum records what that has meant in practice. An identical bill, S.8153-A, died in this same committee in 2022. Another, S.3841, died in this same committee in 2025. A third, S.2440-B, passed the Senate in 2024 and went no further. Three sessions, the same committee, the same result twice.

One detail worth recording while we are in the text: the memorandum describes S9803 as prohibiting discrimination based on “height or weight,” but the section it would actually add to the Executive Law, section 296-e, is titled and drafted in terms of weight alone. Height appears in the memo and not in the statute. We noted the same gap in our reference page on 26 August; reading the bill text again on 30 August confirms it is still there.

Massachusetts: ten signatures, and the clock ran out five months ago

Senate Bill S.1249 of the 194th General Court was presented by Senator Rebecca Rausch and referred to the Joint Committee on the Judiciary on 27 February 2025. The committee held a hearing on 25 November 2025 and reported the bill favorably on 5 February 2026, sending it to the Senate Committee on Ways and Means. That is where it has been ever since.

Massachusetts is the one jurisdiction of the four where “pending” has a countable answer, and the Senate Rules give it twice over. Rule 27C provides two separate routes out of Ways and Means. The first is a floor motion: a majority of members present and voting is enough if the motion is made more than 45 calendar days after referral, and two thirds if it is made earlier. The second route does not involve the floor at all:

In addition to the above procedure, the Committee on Ways and Means shall be discharged from further consideration of a certain matter upon the written petition of a majority of the members of such committee presented to the chair after 45 calendar days following referral of the matter to said committee.

The Senate Committee on Ways and Means had eighteen members on 30 August 2026, counted on the committee’s own membership page. A majority of eighteen is ten. Ten written signatures, delivered to the chair, and the rule says the committee “shall” be discharged. A matter discharged this way counts as favorably reported and goes into the Orders of the Day.

The 45 day waiting period ran out on 22 March 2026. As of 30 August 2026 the bill has been in Ways and Means for 206 days, which is 161 days past the point at which ten signatures would have been sufficient. Neither route has been attempted.

New Jersey: a floor majority, and only one person may ask for it

New Jersey has a companion pair, Senate Bill S1631 and an Assembly version, in the 222nd Legislature. The introduced text of S1631, published by the Office of Legislative Services, is sponsored by Senators Andrew Zwicker of the 16th district and Angela V. McKnight of the 31st, and co-sponsored by Senator Ruiz.

Both chambers adopted rules for this Legislature on 13 January 2026, and both have a discharge provision. They are not the same, and neither is a petition.

Assembly Rule 10:23 requires four things at once. The motion may be made only by the prime sponsor, or, if the bill came from the Senate, by an Assembly member acting on behalf of the Senate prime sponsor. Twenty-four hours’ notice is required. The committee must have met at least three times since the bill was referred to it. And then, in subsection d:

The motion to relieve a reference committee of a bill or resolution shall not prevail unless it receives at least 41 affirmative votes.

Forty-one is a majority of the eighty seat Assembly; the same number appears in Rule 2:2 as the quorum. Rule 10:23(e) adds that the motion may not be offered more than twice for any bill in an annual session, so the attempt is not only hard, it is rationed.

Senate Rule 12:6 is shorter and has a different shape. The prime sponsor or first co-prime sponsor may move; sixty days must have elapsed since referral; twenty-four hours’ notice is required; and the motion needs at least 21 votes, again a majority of the forty seat chamber and again identical to the quorum.

So in New Jersey the answer to “how many” is 41 or 21 depending on the chamber, and the answer to “who” is one specific person. The length of the sponsor list changes neither.

What we could not check today, and are therefore not claiming

The New Jersey Legislature publishes bill status through a page that assembles itself in the browser rather than on the server. On 30 August 2026 neither browser available to us would load it. We could read the bills themselves, which are static documents on the Legislature’s publication server, but not the status pages.

Consequently we are not stating here which committee S1631 currently sits in, and we are not printing a sponsor count for the Assembly companion. Secondary sources give both, and they do not fully agree with one another on the Senate vote that sent the bill across, which is precisely the reason not to repeat them. Those two rows stay open until the primary record is readable again.

What this changes about the word “pending”

A tracker column that says “pending” invites one question, and it is the wrong one: is anybody going to do something? The rules suggest a better one, and it is different in every chamber.

In New York, ask who the introducer is, because nobody else can move. In Massachusetts, ask how many of the eighteen members of Ways and Means have signed, because ten ends it. In New Jersey, ask whether the prime sponsor has given notice, and then count to 41.

Three jurisdictions, three thresholds, and one word covering all of them. We will be adding this column to our reference page on weight discrimination laws, with the rule cited and the date it was read, because “pending” on its own has told us nothing for three sessions running.

Every tracker that lists weight discrimination laws in the United States has a Delaware row, and almost every one of them says the same thing: pending. It is the most reassuring word in the table and the least informative one. It suggests motion. In this case there has been none for sixteen months.

We checked the record of House Bill 115 of the 153rd General Assembly at the Delaware General Assembly’s own legislative information system on 29 August 2026. This is what is actually there, and what it takes for a bill in that position to move.

What the bill would do

HB 115 carries the long title “AN ACT TO AMEND THE DELAWARE CODE RELATING TO THE PROHIBITION OF DISCRIMINATION BASED ON WEIGHT, HEIGHT, OR BODY SIZE.” Its synopsis is broader than most state bills of this kind. It would prohibit discrimination based on weight, height, or body size in transportation, public accommodation, housing, commerce and trade, employment, jury selection, education, and public administration.

The definitions are unusually careful. “Body size” is defined as the physical magnitude, extent, or bulk of a person, including that person’s relative or proportionate dimensions, and it expressly covers “metrics, ratios, measurements, ratings, or scores that include, in whole or in part, weight, height, or body size.” That last clause matters. It reaches the numbers that stand in for a body, not only the body. A rule written in terms of an index rather than a person would still be covered.

Whether that drafting survives contact with a committee is a question the record cannot answer, because the bill has never been through one.

The entire record, in two lines

The bill’s action history at the General Assembly consists of exactly two entries:

• 8 April 2025: Introduced and Assigned to Administration Committee in House
• 14 May 2025: Motion to Release Failed

That is all of it. There is no committee report. There is no roll call of any kind. There are no amendments. The bill’s status line still reads “House Administration 4/8/25”, the same committee it went to on the day it was introduced, and the site’s own explanation of what typically happens next still says a committee hearing takes place within twelve legislative days. That sentence has been true in the abstract and false in this case for sixteen months.

Note what the record does not say. It does not report how the release motion failed or by how much. No vote is recorded against it. The attempt is logged as failed, and the margin is not part of the public record.

What it takes to get a bill out of a committee that will not act

The House adopted its rules for this General Assembly on 14 January 2025 by passing House Resolution 3. Rule 37(b) covers the situation directly: bills not acted upon by the assigned committee within twelve legislative days, where the House prime sponsor has requested action, “can be petitioned out of committee pursuant to Rule 27.”

Rule 27 is titled “Petition of bill or resolution out of committee” and reads in full:

Every bill or resolution which has been in committee for a period of more than twelve (12) legislative days and the Prime House Sponsor has requested that the bill or resolution be acted upon, except those assigned to the Appropriations Committee pursuant to Rule 22, shall, upon written request of the majority of the members elected to the House, be reported to the House for a decision as to its further disposal.

The operative phrase is “written request of the majority of the members elected to the House.” Not a majority of those present, not a majority of the committee. A majority of the whole chamber, in writing.

The Delaware House of Representatives has 41 seats, districts 1 through 41. A majority of the members elected to the House is therefore 21 signatures.

The arithmetic nobody puts in the tracker

HB 115 lists its sponsors on the bill detail page. The prime sponsor is Rep. Sophie Phillips of the 18th district. There is one additional sponsor from the other chamber, Sen. Lockman of the 3rd Senate district, who cannot sign a House petition. The co-sponsors are Reps. Bolden, Gorman, S. Moore, Morrison, Neal, Ross Levin, Burns, and Lambert.

That is nine members of the House of Representatives: the prime sponsor plus eight co-sponsors.

Nine of the twenty-one signatures the rule requires. To get the bill in front of the full House over the committee’s inaction, its supporters would need twelve more members than have put their names on it, and none of those twelve has done so in sixteen months. This is not a claim about whether they would if asked. It is the distance between the bill’s own sponsor list and the threshold in its own chamber’s rules, and it is the single most useful number about HB 115 that no tracker carries.

And the clock has run out for this session

Delaware’s constitution puts a hard edge on the calendar. Article II, § 4(b) provides that the General Assembly may continue in session each calendar year as long as the public interest requires, “however, each session may not extend beyond 5:00 p.m. on the last day of June unless the session is recalled by the Governor or the mutual call of the presiding officers of both Houses.”

The 153rd General Assembly’s 2026 session ran to that edge. The most recent legislative action recorded in the assembly’s own list of recent legislation is dated 1 July 2026. Since then the assembly’s session calendar shows committee meetings and task force meetings, and no session days. As of 29 August 2026, the last time the Delaware legislature acted on any bill was nearly two months ago, and HB 115 was not one of them.

So a bill still described as pending sits in a committee that has not reported it, in a chamber that is not sitting, in a General Assembly whose members face election in November. For it to advance in this General Assembly at all, the session would have to be recalled by the Governor or by the mutual call of both presiding officers.

Why the word is the problem

“Pending” and “failed” are not opposites in a legislative tracker. They are two labels for the same underlying fact, applied at different moments and by different conventions. A bill that has been read once, referred once, and never acted on is pending. So is a bill in active negotiation with a committee vote scheduled. The word cannot tell them apart, and the tables that use it do not try.

This matters beyond Delaware. We built our own reference page of weight discrimination laws in August 2026 and found, in the course of checking every line at the originating legislature, that published lists routinely carry bills that died, bills that are a different bill entirely, and bills whose printed text is narrower than their summaries claim. “Pending” is the same failure in a quieter form: not a wrong fact, but a true word carrying no information.

The fix is not a better adjective. It is the date of the last action, the committee it sits in, and the rule that governs getting it out. For HB 115 those are: 14 May 2025, House Administration, and twenty-one signatures.

What we checked, and what we are not saying

Checked on 29 August 2026 at the Delaware General Assembly’s legislative information system: the bill detail page for HB 115 of the 153rd General Assembly, including its full action history, sponsor list, committee reports, and roll calls; the House Rules as adopted on 14 January 2025; the roster of the House of Representatives; the session calendar; and the recent legislation list. Article II, § 4 was read in the published text of the Delaware Constitution.

We make no prediction about whether HB 115 will pass, in this General Assembly or a later one. Predicting bills is not reporting them. We also take no position here on any question about weight and health. The subject of this article is a legislative procedure and a sponsor count, not a body.

If the record changes, this page will say so, with the date it was checked.

Washington State turns up on almost every list of places that protect fat people from discrimination. It usually sits in the same column as Michigan, sometimes with a footnote, often without one.

There is no such law. The Washington Law Against Discrimination does not list weight, height or body size among its protected grounds, and no legislature has added them. What Washington has is a court decision from 2019, and the decision does something quite different from what a statute would do.

The difference matters, and not as a technicality. It decides what you have to say about your own body before the law will look at your case.

The certified question

The case is Taylor v. Burlington Northern Railroad Holdings, Inc., No. 96335-5, decided by the Washington Supreme Court on 11 July 2019, written by Chief Justice Fairhurst.

It did not arrive there the ordinary way. Casey Taylor had sued in state court in 2010, the case was moved to federal court, and by 2018 it had reached the United States Court of Appeals for the Ninth Circuit. That court found the state-law question unresolved and handed it back, which is what a certified question is. The Ninth Circuit asked exactly this:

Under what circumstances, if any, does obesity qualify as an “impairment” under the [WLAD, RCW] 49.60.040?

Note what is not being asked. Nobody asked whether Washington should ban weight discrimination. The question is narrow: does this condition fit inside a definition the legislature wrote for something else.

What happened to Casey Taylor

In 2007 Taylor received a conditional offer to work as an electronic technician for BNSF Railway. The offer depended on a physical exam and a medical history questionnaire.

The physical exam found that he “[m]eets minimum physical demands of the essential functions of Electronic Technician.” He could do the job. The court’s opinion records that finding in the same paragraph as what followed.

The exam also recorded his height as 5 feet 6 inches and his weight as 256 pounds, a BMI of 41.3. BNSF treated a BMI over 40 as a trigger for further screening. Taylor’s file went to the company’s chief medical officer, and BNSF then told him it could not determine whether he was medically qualified, citing “significant health and safety risks associated with extreme obesity (Body Mass Index near or above 40) and uncertain status of knees and back.”

BNSF offered to reconsider if Taylor paid for a sleep study, blood work and an exercise tolerance test himself. He was unemployed at the time, without medical insurance and without veterans’ benefits, and could not afford them. According to the opinion, BNSF told him that company policy was not to hire anyone with a BMI over 35, and that if he could not pay for the testing, his only remaining option was to lose ten percent of his weight and keep it off for six months.

That is the shape of the thing. A man who passed the physical was told the job was available at the price of a medical bill he could not pay or a body he did not have.

What the court actually held

The Washington Supreme Court answered the certified question broadly:

obesity always qualifies as an impairment under the plain language of RCW 49.60.040(7)(c)(i) because it is a “physiological disorder, or condition” that affects many of the listed body systems.

That statutory subsection is a list of body systems: neurological, musculoskeletal, special sense organs, respiratory including speech organs, cardiovascular, reproductive, digestive, genitourinary, hemic and lymphatic, skin, and endocrine. An impairment under the WLAD is a disorder or condition affecting one or more of them.

BNSF had argued for the narrower federal reading: obesity counts only if some separate underlying physiological disorder caused it. The court refused, on the ground that Washington’s statute is deliberately broader than the federal Americans with Disabilities Act and that the legislature had said so.

Two consequences follow, and both are in the opinion. For a disparate treatment claim, the person does not have to show they actually have the condition, only that the employer perceived it. For a reasonable accommodation claim, they do have to have it in fact, plus meet the further requirements of RCW 49.60.040(7)(d).

There is also a boundary the court drew in a footnote, and it is the sentence that most summaries drop: “Merely being overweight is not an impairment under the WLAD, but obesity is.”

The mechanism, spelled out

This is the part that gets lost when Washington is listed next to Michigan.

Michigan’s Elliott-Larsen Civil Rights Act names weight as a protected characteristic. A person in Michigan who is refused a job because of their size points at the ground itself. Nothing further is required of them.

Washington has no such ground. The route runs entirely through the disability definition in RCW 49.60.040(7). To be protected, a person’s body has to be classified as an impairment, which under this ruling means classified as a physiological disorder or condition. The court was explicit about the classification it was making. Answering BNSF’s argument that weight is just a physical trait, it wrote: “Obesity is not a physical trait. It is a disease.”

So the protection is real and it is conditional. It exists because a court placed fat bodies inside a medical category. It is disability law doing the work of body-size law.

Readers of this magazine will recognise the shape from somewhere much closer to home. Germany’s General Equal Treatment Act lists six grounds and body size is not among them, so claims there are routed through disability as well. We have written about what that detour does to the numbers: a ground nobody records produces no cases, and no cases gets read as no problem. Washington took the same detour and arrived somewhere better, which tells you the detour can work. It does not tell you the detour is free.

The dissent saw the seam

Justice Yu dissented, and her disagreement is narrower and sharper than a headline would suggest.

She agreed that obesity need not be caused by some separate disorder to count. She agreed that obesity is distinct from weight, which is a physical trait. She agreed there is a growing consensus in medicine treating obesity as a disease in itself.

What she rejected was the word always. Her objection is that the line between the categories is drawn by a formula: weight in relation to height. She noted that BMI does not distinguish weight carried as muscle from weight carried as fat. She would have required an individualised inquiry in each case rather than a categorical rule.

Read from outside the courtroom, the majority and the dissent are arguing about which unsatisfying option to take. One puts every fat body in a disease category automatically. The other makes each person prove their body qualifies. Neither judge had the option a legislature has, which is to protect people from being treated badly because of their size, and to leave their diagnosis out of it.

Has anything changed since 2019?

We checked, because a seven-year-old ruling is only good law if nothing overtook it.

RCW 49.60.040 has been amended twice since the decision. In 2020, House Bill 2602, Washington’s version of the CROWN Act, defined race as inclusive of traits historically associated or perceived to be associated with race, including hair texture and protective hairstyles. In 2024, Engrossed Substitute Senate Bill 5788 added definitions for service animal trainees and service animal trainers.

Neither touched subsection (7). The impairment definition reads today word for word as the court quoted it in 2019. And neither added weight, height or body size to the grounds the statute protects.

So the position is unchanged, and so is the gap. Washington protects fat people through a disability classification decided by a court, not through a characteristic named by a legislature. On our tracker of weight discrimination law it now has its own row, and that row says court decision, not statute.

Checked 27 August 2026.

Sources

• Washington Supreme Court, Taylor v. Burlington Northern Railroad Holdings, Inc., No. 96335-5, filed 11 July 2019 (slip opinion, majority by Fairhurst C.J., dissent by Yu J.): https://www.courts.wa.gov/opinions/pdf/963355.pdf
• Ninth Circuit certification order quoted therein: Taylor v. Burlington N. R.R. Holdings, Inc., No. 16-35205 (9th Cir. 17 September 2018)
• Washington State Legislature, RCW 49.60.040, current text and amendment history: https://app.leg.wa.gov/rcw/default.aspx?cite=49.60.040
• Washington State Legislature, RCW 49.60.030, protected grounds: https://app.leg.wa.gov/RCW/default.aspx?cite=49.60.030

Ask the internet whether it is legal to refuse someone a job for being fat, and you get a list. The lists disagree with each other, and several of them are wrong in the same way: they count a bill that died as a law that passed.

This page is our attempt to keep one list that is checked at the source. Every row below was verified against the parliament’s own bill page, not against a law-firm newsletter, an advocacy tracker or a summary. The check date is on every row. When a row is out of date, it is because we have not re-checked it yet, not because we are guessing.

How to read this page

Three things make this subject easy to get wrong, and all three are avoidable.

Bill numbers repeat. Most parliaments start counting again at the beginning of each session. S.23 in one Vermont session and S.23 in the next are two unrelated bills. So is S.1249 in the 193rd and the 194th Massachusetts General Court. Every number on this page is given with its session. A number without a session is not a citation.

“Introduced” is not “advancing”. A bill can be introduced by ten sponsors, generate a press release and a wave of coverage, and then sit in one committee until the session ends. That is the ordinary outcome, not an unusual one.

The memo is not the text. A sponsor’s explanatory memo and the printed bill text are separate documents, and they do not always cover the same ground. One bill on this page is described in its own memo as covering height and weight, while the text as printed covers weight alone.

In force

Jurisdiction	Instrument	Covers	Key dates	Checked
Michigan (US state)	Elliott-Larsen Civil Rights Act, Public Act 453 of 1976	Height and weight, alongside religion, race, colour, national origin, age, sex, marital status	Enacted 1976, effective 31 March 1977	26 Aug 2026
New York City	Local Law 61 of 2023, from Int. 0209-2022, amending the NYC Human Rights Law	Actual or perceived height and weight in employment, housing and public accommodation, with stated exceptions	Signed 26 May 2023, effective 22 November 2023	26 Aug 2026
Minneapolis	Title 7 of the Minneapolis Code of Ordinances, Civil Rights Ordinance, as amended	Height and weight, defined as a numerical measurement of body height, weight or size, and expressly including perception	Council approved 1 May 2025, mayor approved 5 May 2025, effective 1 August 2025	26 Aug 2026

Michigan is the only US state on this list, and has been since the Ford administration. That is the single most useful fact about the state of this law: nearly fifty years, one state.

The Minneapolis amendment is the most recent and the most carefully drafted of the three, because it addresses perception directly. A rule that only protects measured bodies does not reach the manager who decides someone looks too fat for the front desk. Minneapolis says the protection applies whether or not the measurement matches.

Pending

Jurisdiction	Bill and session	Last recorded action	Where it sits	Checked
New Jersey	S1631, 222nd Legislature (2026–2027)	Passed the Senate 24–14 and referred to the Assembly Judiciary Committee, both 24 February 2026	Assembly Judiciary Committee	26 Aug 2026
New Jersey	A4563, 222nd Legislature (2026–2027), companion to S1631	Introduced and referred, 10 March 2026	Assembly Judiciary Committee	26 Aug 2026
New York State	S9803, 2025–2026 session	Introduced and referred, 6 April 2026	Senate Investigations and Government Operations Committee	26 Aug 2026
Massachusetts	S.1249, 194th General Court (2025–2026); House companion H.1919 not separately checked	Reported favourably by the Judiciary Committee and referred to Senate Ways and Means, 5 February 2026	Senate Ways and Means	26 Aug 2026
Delaware	HB 115, 153rd General Assembly (2025–2026)	Motion to release from committee failed, 14 May 2025	House Administration Committee	29 Aug 2026

Four of these five rows deserve a sentence each, because the one-word status hides the useful part.

New Jersey is the furthest along and has been here before. S1631 is the carry-over of S1602 of the 2024–2025 session, which also passed the Senate and also landed in the Assembly Judiciary Committee, where it stopped. The bill would add height and weight to the Law Against Discrimination itself, in the same list as race, creed, colour, national origin, ancestry, age, sex, gender identity or expression, sexual orientation, marital status, familial status, military service, disability and nationality. Passing one chamber twice is real progress and is also not a law.

New York State is the row where the memo and the text diverge. The sponsor’s memo describes a bill prohibiting discrimination based on height or weight across employment, housing, public accommodation, credit, internships and education. The printed text of S9803 adds a single new section, Executive Law § 296-e, covering weight. Height does not appear in the operative text. Anyone citing this bill as a height-and-weight bill is citing the memo. The predecessor, S2440-B, passed the Senate in the 2023–2024 session and went no further; S3841 of 2025 died in the same committee this bill now sits in.

Massachusetts is where a number collides with itself. In the 194th General Court, S.1249 is “An Act prohibiting body size discrimination”, filed by Senator Rebecca Rausch. In the 193rd, S.1249 was “An Act relative to reducing administrative burden”, a mental-health bill by a different senator, which died in Senate Ways and Means on the last day of 2024. Two bills, one number, four years apart. This is the most common way a tracker goes wrong.

Delaware looks pending and is barely breathing. HB 115 was introduced on 8 April 2025 with ten sponsors and assigned to the House Administration Committee. On 14 May 2025 a motion to release it from that committee failed. That is the last recorded action. As of today the bill has sat in the same committee for sixteen months, with no committee report, no roll call and no amendment on file. It is technically alive and functionally stalled, and a tracker that prints “pending” for it says nothing useful. Two things we checked on 29 August 2026 make that concrete. Getting a bill out of an unwilling committee takes the written request of a majority of the members elected to the House under House Rule 27, which is 21 of 41 seats; nine House members have put their names on HB 115. And the session has closed: the most recent legislative action recorded by the assembly is dated 1 July 2026, with no session days on the calendar since. We walk through both in Delaware HB 115: what “pending” hides.

Failed

Jurisdiction	Bill and session	What happened	Checked
Vermont	S.23, 2023–2024 session	Introduced 19 January 2023 by Sen. Ruth Hardy, one committee hearing on 24 February 2023, no further action, no act	26 Aug 2026

Vermont is the reason this page exists. Search for it and you will find sources treating Vermont as a jurisdiction with weight-discrimination protection, sometimes attaching a session-law number to it. There is no such act. What exists is a bill from the 2023–2024 session that got a single hearing and stopped. S.23 of the 2025–2026 session is an entirely different bill, about synthetic media in elections, and it has been sitting in the Government Operations Committee since 22 January 2025. Two numbers, two sessions, one confident and wrong entry in a lot of lists.

No ground in federal law

Jurisdiction	Instrument	Position	Checked
Germany	§ 1 Allgemeines Gleichbehandlungsgesetz (AGG)	The listed grounds are race or ethnic origin, gender, religion or belief, disability, age and sexual identity. Weight, height and body size are not among them	26 Aug 2026

Germany has no equivalent to Michigan, to New York City or to Minneapolis, at federal or state level. What it has is a closed list of six grounds, and body size is not one of them. Claims are sometimes routed through disability law instead, which requires the person to be classified as disabled first. We wrote about what that does to the numbers in our piece on Germany’s discrimination survey: a ground that is not surveyed produces no cases, and no cases is then read as no problem.

Protected by court decision, not by statute

Jurisdiction	Instrument	Covers	Key dates	Checked
Washington (US state)	Taylor v. Burlington Northern Railroad Holdings, Inc., No. 96335-5, Washington Supreme Court. No statutory ground: the WLAD does not list weight, height or body size	Obesity as an “impairment” under RCW 49.60.040(7)(c)(i), and therefore as a disability. Merely being overweight is expressly not covered. Perception is enough for a disparate treatment claim	Certified question from the Ninth Circuit 17 September 2018, decided 11 July 2019. RCW 49.60.040 amended in 2020 and 2024 without touching subsection (7)	27 Aug 2026

Washington belongs in its own section because the mechanism is different in kind, not in degree. Michigan names weight as a ground and a person points at the ground. Washington has no such ground, so protection runs through the disability definition, which means a person’s body has to be classified as a physiological disorder or condition first. That is a court’s reading of a definition written for something else, and it is the same detour German claims take through the AGG. We set out what the ruling says and where it stops in our piece on the difference between a law and a ruling.

What is deliberately not on this page yet

Other jurisdictions appear on published lists and are plausibly correct. San Francisco, Santa Cruz, Madison, Urbana, Binghamton and Washington DC are all cited as having body-size or personal-appearance protection; New Jersey A3893 and a Connecticut proposal both show up in coverage.

None of them are in the tables above, because we have not yet read them at the source. They will be added one at a time, each with its own check date, and if one of them turns out to be another Vermont we will say so.

What this page is not

This is a record of what the law says and where each instrument stands, on the date given. It is not legal advice, and none of us is your lawyer. If you think you have been discriminated against, the useful next step is someone qualified in your jurisdiction, not a table on the internet.

Sources

• Michigan Legislature, Elliott-Larsen Civil Rights Act, Act 453 of 1976: https://www.legislature.mi.gov/documents/mcl/pdf/mcl-Act-453-of-1976.pdf
• NYC Commission on Human Rights, height and weight: https://www.nyc.gov/site/cchr/media/height-and-weight.page
• New York City Council, Int. 0209-2022: https://legistar.council.nyc.gov/LegislationDetail.aspx?ID=5570369&GUID=DF289A07-73A5-4AFE-8932-7EA5D1FA6577
• City of Minneapolis, expanded civil rights protections: https://www.minneapolismn.gov/news/2025/august/new-civil-rights-protections
• Minneapolis Civil Rights Ordinance, Title 7: https://lims.minneapolismn.gov/Download/FileV2/49538/Civil-Rights-Ordinance.pdf
• New Jersey Legislature, S1631 text, 222nd Legislature: https://pub.njleg.gov/Bills/2026/S2000/1631_I1.HTM
• New York State Senate, S9803, 2025–2026: https://www.nysenate.gov/legislation/bills/2025/S9803
• Massachusetts General Court, S.1249, 194th: https://malegislature.gov/Bills/194/S1249
• Massachusetts General Court, S.1249, 193rd, for contrast: https://malegislature.gov/Bills/193/S1249
• Delaware General Assembly, HB 115, 153rd: https://legis.delaware.gov/BillDetail?legislationId=142056
• Vermont General Assembly, S.23, 2023–2024: https://legislature.vermont.gov/bill/status/2024/S.23
• Vermont General Assembly, S.23, 2025–2026, a different bill: https://legislature.vermont.gov/bill/status/2026/S.23
• § 1 AGG: https://www.gesetze-im-internet.de/agg/__1.html

All rows last checked 26 August 2026.

What “pending” costs: the exit rule, by chamber

“Pending” says a bill is in a committee. It does not say what it would take to get it out, and that differs by chamber. We read the rules in the original on 30 August 2026. In the New York Senate there is no threshold at all: Rule VI section 2 provides that a motion to discharge a bill out of committee by any member who is not the introducer “shall be out of order”, so S9803 can be moved only by Senator Sepúlveda. In the Massachusetts Senate, Rule 27C discharges the Committee on Ways and Means on the written petition of a majority of its own members after 45 calendar days; the committee had eighteen members on 30 August 2026, so the number is ten, and the 45 days for S.1249 ran out on 22 March 2026. In the New Jersey General Assembly, Rule 10:23 lets only the prime sponsor move, requires the committee to have met three times, and needs 41 affirmative votes of the eighty seat chamber; the New Jersey Senate equivalent, Rule 12:6, requires 60 days and 21 votes of forty. Full working: The Number No Tracker Prints.

On 7 May 2026 the National Institute for Health and Care Excellence published technology appraisal TA1152. It recommends semaglutide, up to a maintenance dose of 2.4 mg once weekly, for reducing the risk of major adverse cardiovascular events in adults who have established cardiovascular disease and a body mass index of at least 27 kg/m².

The NHS in England had to fund it within 90 days of publication. Counted from 7 May, that deadline fell on 5 August 2026.

This is the first appraisal in our archive that recommends the injection without arguing from weight loss. The endpoint is cardiovascular death, non-fatal heart attack and non-fatal stroke. Weight is not the outcome being bought.

And yet the door into the recommendation is still a BMI number. NICE says so itself, in the same document, and then explains why it is leaving it there.

What the appraisal actually says

The evidence is SELECT, a multinational randomised double-blind placebo-controlled phase 3 trial with 17,604 participants, all with a BMI of at least 27 kg/m² and established cardiovascular disease. Established disease meant a previous heart attack, a previous ischaemic or haemorrhagic stroke, or symptomatic peripheral arterial disease. Semaglutide plus standard care (n=8,803) was compared with placebo plus standard care (n=8,801).

The primary endpoint was time to a first major adverse cardiovascular event. The hazard ratio was 0.80, with a 95% confidence interval of 0.72 to 0.90.

The direction of effect was consistent across the individual components, but not all of them held up on their own. Non-fatal myocardial infarction (HR 0.72, 95% CI 0.61 to 0.85) and coronary revascularisation (0.77, 0.68 to 0.87) did. Non-fatal stroke (0.93, 0.74 to 1.15), cardiovascular death (0.85, 0.71 to 1.01), hospitalisation for unstable angina (0.87, 0.67 to 1.13) and heart-failure hospitalisation (0.79, 0.60 to 1.03) all had confidence intervals that cross 1. That is unremarkable for a composite endpoint, whose components are not individually powered. It is still worth saying plainly, because “cuts heart attacks and strokes” gets repeated as though both had been shown separately. Heart attacks were. Strokes were not.

The company that submitted the evidence is Novo Nordisk. Semaglutide can only be used under a commercial arrangement, and the agreed price is confidential. The published cost-effectiveness range therefore rests on a figure the public cannot see. NICE’s preferred incremental cost-effectiveness ratios ran from £6,878 to £14,594 per quality-adjusted life year, against a threshold of £20,000.

One thing this article does not do: tell anyone whether to take semaglutide. SELECT is a secondary-prevention trial. Everyone in it had already had a cardiovascular event. Nothing in it says anything about people who have not. This piece is about how the rule was built, not about the drug.

Section 3.5: the effect arrives before the weight loss does

In section 3.5, the external assessment group records something that undercuts the usual story:

The EAG noted that the clinical effectiveness of semaglutide in reducing the risk of MACE was seen shortly after starting treatment, before any substantial effect on weight loss was reported. This shows that there is a mechanism of action independent of weight loss.

Read plainly: the cardiovascular benefit showed up too early to be explained by getting smaller. Whatever is protecting these hearts, it is not the number on the scale.

The lead team used this to widen the recommendation, not narrow it. Because risk is highest shortly after a cardiovascular event, and because the benefit does not have to wait for weight loss, it concluded the recommendation should not be restricted by time since the event.

Section 3.9: and the lifestyle programme does not do much either

Section 3.9 is an argument about money, which is why it is more revealing than the clinical sections.

The company’s economic model included no cost at all for healthy lifestyle counselling, in either arm. The lead team had to decide whether that was acceptable, given that SELECT delivered counselling nine times in the first year and four times a year thereafter. It concluded:

It recalled that the effect of semaglutide was seen soon after starting treatment (see section 3.5), which suggested that the benefit of semaglutide was independent of weight loss. So, it was likely that the additional benefit of semaglutide was mostly independent of the lifestyle interventions offered.

So the lifestyle programme was judged unimportant enough to leave out of the costings.

Now read recommendation 1.1, from the same document:

Semaglutide (up to a maintenance dose of 2.4 mg once weekly) can be used, within its marketing authorisation, alongside a reduced-calorie diet and increased physical activity, as an option for reducing the risk of a major adverse cardiovascular event.

The diet is in the recommendation. It is not in the budget. In the economics it is worth nothing; in the prescription it is a condition. That is not a rounding error, it is two different jobs being done by the same sentence. One of them is accounting. The other one is telling patients what they owe.

Section 3.11: NICE names the problem and then declines it

The equality section is the sharpest part of the document, because NICE states the objection against its own criterion and then explains why it will not act on it.

The lead team noted that people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds are at a higher risk for CVD at lower BMI thresholds. This means that BMI-based criteria for treatment eligibility may not account for ethnic variations in risk.

The lead team acknowledged this. It then noted that recommending semaglutide below a BMI of 27 would fall outside the marketing authorisation, and that there was no safety or efficacy evidence below that threshold to justify it. It concluded that recommending in line with the marketing authorisation across all groups would protect patient safety and was a legitimate aim.

That reasoning is internally sound. NICE cannot recommend outside a licence, and it cannot invent evidence it does not have. The consequence still stands: a threshold that NICE has recorded as a poor proxy for cardiovascular risk in several populations remains the entry condition, and the reason it remains is regulatory, not medical.

There is a second group in the same section. The lead team noted that people with language difficulties or cognitive impairments may find it harder to adhere to a treatment plan or to self-administer an injection. Access does not stop at eligibility.

What this makes the BMI

Put the three sections together.

The benefit does not come from weight loss (3.5). The lifestyle programme attached to it is not doing the work either (3.9). The threshold is known not to track risk equally across populations (3.11). And it is still the threshold.

At that point the BMI is no longer functioning as a medical criterion for this indication. It is functioning as a distribution key: a cheap, universally recorded number that decides who is inside the funded population and who is outside it. That is a defensible thing for a rationing system to need. It is not the same thing as a clinical reason, and the two get spoken as though they were.

That matters beyond the paperwork, because a rule that hands out treatment by body size teaches something about bodies. We have written before about what happens in the consulting room when weight becomes the explanation for everything. TA1152 shows the same move one level up, written into national funding policy: the number gets the last word even where the document itself says the number is not what is doing the healing.

Germany: the same logic, the opposite result

Here the comparison gets genuinely strange, and it turns on a single word in a licence.

In the European Union, semaglutide under the brand Wegovy is authorised for weight management. The EMA’s public information describes it as used together with diet and physical activity to help people lose weight and keep their weight under control, in adults with a BMI of 30 or more, or a BMI of at least 27 who have weight-related health problems. The examples of those problems include “a history of heart attack, stroke or blood vessel problems.”

Look at what that does. The exact population NICE treats as cardiac patients appears in the European licence as people whose heart attack is a reason to treat their weight. Same drug, same people, and the stated purpose is reversed.

Germany then attaches its funding rule to that stated purpose. Under section 34(1) sentence 7 of the German Social Code Book V, medicines used for weight reduction have been excluded from statutory health insurance since 2004 as so-called lifestyle drugs. On 21 March 2024 the Federal Joint Committee formally listed Wegovy in Annex II of the pharmaceuticals directive. Its own statement is explicit about the mechanism:

Because of the therapeutic indication “weight regulation,” the statutory prescribing exclusion applies.

The committee also recorded that it had considered demands for an exception at higher body weights, given the raised risk of accompanying and secondary conditions, and found it had no discretion to grant one. The same statement notes that Wegovy cannot be included in Germany’s disease management programme for obesity either, for the same reason.

Meanwhile Ozempic and Rybelsus, the same active substance under different names and licensed for type 2 diabetes, are reimbursed normally.

So the chain runs like this. The cardiovascular benefit is real enough for NICE to fund the drug in England. In the EU it sits inside a weight-management licence rather than a cardiovascular one. In Germany a weight-management licence is precisely what triggers the exclusion. The better the drug looks at protecting hearts, the more firmly it stays outside German reimbursement, because the label under which that protection is documented is the label the law refuses to pay for.

One thing we could not establish: whether the Federal Joint Committee would revisit its decision if the licence itself were ever rewritten. We could not read the full reasoning document behind the 2024 decision, so we are flagging that as an open question rather than asserting an answer.

We described the cross-border version of this problem when France paid and Germany did not. TA1152 adds the part that is easier to miss: the deciding factor is not how well the drug works, and not who needs it. It is which sentence a regulator wrote on the box.

Why we are reading appraisal documents at all

Because this is where the sentences that follow people into consulting rooms get written, and because the contradictions are usually visible in the text itself if anyone reads past the summary.

It is the same reason we read the ACP position paper that asked for coverage and stigma reduction in one breath, and the AIHTA report from Vienna whose structural recommendations nobody quotes. Institutions rarely hide the tension. They print it in section 3 and trust that the press release is what gets read.

TA1152 printed it three times. The effect is not from the weight. The lifestyle programme is not doing the work. The threshold does not track the risk. And the threshold is still the door.

---

Sources: NICE, Semaglutide for reducing the risk of major adverse cardiovascular events in people with cardiovascular disease and overweight or obesity (TA1152), published 7 May 2026, sections 1.1, 3.3, 3.5, 3.9 and 3.11. European Medicines Agency, Wegovy. Gemeinsamer Bundesausschuss, G-BA vollzieht den gesetzlichen Verordnungsausschluss für das Abmagerungsmittel Wegovy nach, 21 March 2024.

This article reports on how funding rules are built. It is not medical advice and contains no recommendation for or against any treatment.

On 4 August 2026 the American College of Physicians published a position paper in Annals of Internal Medicine titled “Public Policy Approaches to Addressing Adult Obesity”. It is freely readable, which is worth saying, because most of what gets written about it comes from the press release.

The paper contains ten recommendations. Recommendation 1 asks all payers to cover a full package of treatment, including weight loss surgery. Recommendation 4 asks for initiatives against weight bias and stigma. Both sentences are in the same document, approved by the same committee, on the same day.

That is not a contradiction. It is an asymmetry, and it is measurable.

What the document is

The authors are Ryan Crowley, Micah Beachy and Priscilla Carr, writing for ACP’s Health and Public Policy Committee. The committee scanned English-language literature and government and think tank sources, then drafted recommendations with input from ACP’s Board of Governors, Board of Regents, Medical Practice and Quality Committee, Council of Early Career Physicians, Council of Student Members, Council of Resident/Fellow Members and Council of Subspecialty Societies. The Health and Public Policy Committee approved the paper on 23 February 2026, the Board of Regents on 14 April 2026.

Read that list again. Every body named is a body of physicians, students or physician subspecialties. No patient organisation, no advocacy group, no representation of the people the paper is about. That is normal for a professional society. It matters for the fourth recommendation.

ACP is the largest medical specialty organisation in the United States, with 163,000 members. Its members are the people who deliver, refer and bill for the interventions the paper wants covered. Naming that is not an accusation, it is the standing interest behind the text, the same way we placed AIHTA in the health system before citing it.

Recommendation 1, and what it asks for

ACP recommends that all payers cover a consistent, comprehensive package of evidence-based obesity interventions, including obesity prevention and screening services, intensive lifestyle treatment, pharmacologic treatments, and weight loss surgery.

Three sub-points follow: all payers including Medicare and Medicaid should cover medications, ACP opposes onerous restrictions, ACP supports reducing prices. The text underneath names addressees and instruments. Congress should eliminate the ban on Medicare coverage of weight loss drugs. State Medicaid programmes must base coverage packages on clinical guidelines. ACP calls for transparency, standards and regulation for pharmacy benefit managers. It supports expanded drug price negotiation and reference pricing.

That is what a policy demand looks like when someone means it. Named body, named instrument, named change in law.

The paper is also candid about the arithmetic. It states that savings from avoided illness are unlikely to fully offset the cost of covering the drugs through Medicare. And among the cost control options it lists, one sits in a single subordinate clause: “limiting access to low-value services.” A paper asking for universal coverage also names access limits as a cost lever. It does not say which services, and it does not come back to the question.

Recommendation 4, and what it asks for

ACP supports initiatives to reduce bias and stigma associated with obesity and larger body sizes and encourages use of person-first language when referring to people with obesity. ACP encourages all health care settings to provide appropriate accommodation for people with obesity.

Now count. No payer. No statute. No agency. No funding line. No enforcement. Two verbs, “supports” and “encourages,” both of which commit nobody to anything.

The supporting text runs to two paragraphs. One cites Westbury and colleagues calling for more research on stigma, messaging and educational campaigns. The other reports that the American Diabetes Association’s Obesity Association recommends training on weight bias plus appropriately sized chairs, examination tables, gowns and blood pressure cuffs. Those are the concrete items in this section, and ACP reports them as somebody else’s recommendation rather than issuing them as its own.

Compare that with the AIHTA report from Vienna, which put the same equipment list in its own recommendations: step-free entrances, armrest-free seating, scales with a range to 300 kilograms, a private place to be weighed. AIHTA is a state agency with no billing interest and it took ownership of the list. ACP, whose members own the waiting rooms, cites it.

The language rule

“Encourages use of person-first language when referring to people with obesity” is a vocabulary instruction. It is also the one item in Recommendation 4 that is fully actionable, requires no money, and can be complied with immediately.

Person-first language was developed in disability advocacy and adopted by medical bodies to separate a person from a diagnosis. Parts of the fat acceptance movement reject it for exactly that reason and use “fat” as a plain descriptor, because “person with obesity” keeps the diagnosis and only moves it one word to the right. This magazine uses “fat” for that reason.

The paper does not mention that this disagreement exists. A committee of physicians, with no patient or community body in its approval chain, sets the term for a group it is describing. That the term is the polite one does not make the procedure a consultation.

The stigma theory in one sentence

The background section states: “Weight stigma and bias are common and are caused in part by the misconception that overweight and obesity result solely from lifestyle and diet choices.”

That is the whole causal model, and it explains the shape of Recommendation 4. If stigma follows from a wrong belief about causation, then the remedy is better education about causation, which is Recommendation 5, training for medical educators and students. It is the same mechanism we found in the anti-bias training literature: shift the belief, measure the attitude, expect the treatment to follow. The meta-analytic result there was movement in what students say and no significant movement in what is measured below self-report.

The paper’s own numbers describe what the model has to overcome. Twenty percent of US adults report having experienced weight bias in health care. A 2020 international consensus statement, quoted in the paper, found that many health care professionals “hold negative attitudes about obesity, including stereotypes that affected patients are lazy, lack self-control and willpower, are personally to blame for their weight, and are noncompliant with treatment.” The consequence, again from the paper: patients who experience weight bias are less likely to undergo regular examinations and screening, and more likely to delay an appointment.

So the document establishes that the encounter is the problem, and then asks for coverage of what happens inside that encounter with binding language, and for the encounter itself to improve with non-binding language. If you have been told your knee pain is a weight problem, that ordering is not academic.

Two places where the paper cites better than it summarises

The trend. The paper opens with “The U.S. adult population with obesity has grown steadily over the past 2 decades,” and ACP president Jan Carney is quoted in the press release with “rates of obesity steadily rising.” The figure of 40 percent comes from the CDC, and the paper cites the right source for it: NCHS Data Brief No. 508, September 2024, covering August 2021 to August 2023. Prevalence there is 40.3 percent, severe obesity 9.4 percent. We read it.

The same brief reports that from 2013 to 2014 through August 2021 to August 2023 the age-adjusted prevalence of obesity in adults did not change significantly. The cycle values are 37.7, 39.6, 41.9 and 40.3 percent. What did rise significantly is severe obesity, from 7.7 to 9.7 percent. Over twenty years the increase holds. Over the last decade it does not, and the source that says so is the paper’s own reference 3.

BMI. The appendix calls body mass index “a commonly used but flawed tool,” notes that it does not measure body fat or account for muscle and bone mass, that its cutoffs rest on populations that may not be representative, and that the World Health Organization recommends lower thresholds for certain Asian subgroups. The CDC brief says the same about its own measure.

Then the coverage architecture the paper endorses keeps running on that measure. The 2018 US Preventive Services Task Force recommendation it cites triggers at BMI 30 and above. Medicare covers bariatric surgery at BMI 35 and above with a comorbidity and documented failed attempts. Many state Medicaid programmes attach BMI thresholds and documentation of prior weight loss attempts. A tool called flawed in the appendix is the tool that decides who gets the package in Recommendation 1. The paper asks for research into alternatives to BMI. It does not ask for the thresholds to be reconsidered in the meantime.

What would make the fourth recommendation as serious as the first

Not more sympathy. The same grammar.

Recommendation 1 names Congress, Medicaid programmes and pharmacy benefit managers. A Recommendation 4 built to the same specification would name the accreditation bodies that inspect facilities, tie equipment provision to conditions of participation in Medicare and Medicaid, and support adding body weight to anti-discrimination statutes, which is precisely the regulatory step the Vienna report recommends and which German law still does not take.

None of that is in the text. What is in the text is a sentence supporting initiatives, and a preferred noun phrase.

This is not an argument against covering treatment, and nothing here says whether anyone should or should not seek any of it. That is not our subject and not our business. The subject is what a document does when it puts two demands side by side and gives only one of them teeth.

---

Sources. Crowley R, Beachy M, Carr P, for the Health and Public Policy Committee of the American College of Physicians. Public Policy Approaches to Addressing Adult Obesity: A Position Paper From the American College of Physicians. Annals of Internal Medicine, 4 August 2026, doi:10.7326/ANNALS-26-00864 (full text, free). ACP press release, 3 August 2026, acponline.org. Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and severe obesity prevalence in adults: United States, August 2021 to August 2023. NCHS Data Brief No. 508, September 2024.

Two documents sit side by side, and at first glance they contradict each other.

One is Project Report No. 160 from AIHTA, Austria’s health technology assessment agency, published in Vienna in November 2024. Its conclusion: the strongest evidence is for multi-day and multi-week training courses.

The other is the meta-analysis by Jayawickrama and colleagues, which we covered in August. Its finding: anti-bias training changes what students say about fat patients, not what shows up when you measure below the level of self-report.

Put those two sentences next to each other and you get the familiar shrug: studies disagree, pick the one you like. That is not what is happening here. The two do not measure the same thing, they do not count in the same way, and they were not even written at the same time. Sort that out and no contradiction is left. Something less comfortable is.

What the Vienna report is

AIHTA is neither an advocacy organisation nor a treatment provider. It is Austria’s HTA agency, the body that prepares evidence for decisions inside the health system. For the German-speaking world that matters. Most of the sources this magazine relies on come either from the movement itself or from organisations with a commercial interest in treatment. This is the first state-backed evidence report on the subject in German.

The authors are Sarah Wolf and Julia Kern. The systematic search ran from 21 to 23 May 2024 across five databases. For the first research question, which strategies are recommended, they included 13 guideline papers and 13 reviews. For the second, what actually works, 30 primary studies.

The report is unusually clear about its own limits, and those belong in any citation of it. The effectiveness analysis explicitly claims no completeness: only studies published from 2014 onward, and only from Europe, North America, Australia or New Zealand. The trustworthiness of the guidelines used was not systematically assessed. Nine of the 13 reviews are non-systematic, and most of those give no information about their methods, their literature search, or what they included.

Above all, the evidence base is overwhelmingly American. Nine of 13 guideline papers, six of 13 reviews and 19 of 30 effectiveness studies come from the United States. AIHTA writes in its own critical reflection that transferability to Austria is therefore questionable, and it does not blame culture alone. In the US there is an established debate and correspondingly many tested measures; in Austria the focus has so far been on the medical perspective. The same caveat applies to Germany.

What it says, and what it does not

In the summary, one word about health professionals should not be skimmed past. For multi-day seminars or courses, the effectiveness analysis reports “controversial” results, based on three studies. Beliefs about fat patients improved. There were no significant changes in external weight bias, in attitudes toward patients, in communication with them, in their quality of life, or in their health status.

For students the picture is somewhat better. Long-term seminars showed significant improvements; one-day courses were inconsistent. Training improved students’ ability to recognise discrimination and strengthened empathy.

From this the discussion section concludes that multi-day training has the most evidence with the strongest indications of positive effects, and the conclusion states that the strongest evidence currently exists for multi-day to multi-week training. Both are relative statements. “Most evidence” here means three studies for staff, a few more for students, and effects that the conclusion itself describes as “mostly only short-term.”

One phrasing that circulates in coverage of the report is not in it: AIHTA nowhere calls multi-day training “most promising.” It says that is where the most evidence sits. Those are different claims.

Why this is not a contradiction

Three reasons, in ascending order of importance.

First, chronology. The AIHTA search closed on 23 May 2024. The Jayawickrama meta-analysis went online on 8 October 2024. The Vienna report could not have included it. These are not two camps. They are two points in time.

Second, method. AIHTA ran no meta-analysis. It summarises narratively and counts how many studies showed a significant change. Jayawickrama pools effect sizes across 35 studies and reports confidence intervals. A counted “three of three studies improved” and a pooled g are not competing answers to one question. They are two different questions.

Third, and this is the actual point, the endpoint. The AIHTA report lists the measurement instruments used across its included studies: twelve for explicit weight bias, six for internalised bias, four for empathy, and exactly two for implicit weight bias, both of them versions of the Implicit Association Test. The evidence Vienna draws its statement from is therefore almost entirely self-report. And self-report is precisely where Jayawickrama also finds an effect: explicit g = -0.31, confidence interval -0.43 to -0.19. What does not move is measured implicit attitude: g = -0.12, confidence interval -0.26 to +0.02, not significant.

So both reports say the same thing. What people say about fat patients can be shifted by training. What sits underneath was barely measured in Vienna, and was measured in the meta-analysis and did not shift.

Two further details point the same way. AIHTA notes that follow-up periods in most included studies were too short to show long-term effects. And it warns explicitly that training which is not sensitive and well structured can unintentionally reinforce existing bias. That is the same content as Jayawickrama’s prediction interval, which runs from -0.93 to +0.31: the next training can also go the wrong way.

Anyone citing either source as “training works” or “training does nothing” is citing it wrong. Neither sentence appears in either document.

The part they share that nobody quotes

The AIHTA report is not only an effectiveness analysis. Its first half collects recommendations, and there sits a checklist more concrete than anything in the training debate. Sixteen sources, eight guideline papers and eight reviews, recommend structural measures:

• step-free, accessible entrances
• wide seating without armrests in waiting rooms
• accessible toilets with grab rails
• a private place to be weighed, and the option of being weighed without having to see the number
• blood pressure cuffs, tape measures, examination instruments and gowns in appropriate sizes
• scales with a measuring range of 150 to 300 kilograms
• examination tables, chairs and hospital beds of adequate width and load capacity
• no stigmatising imagery on walls, in magazines, on the website or on social media, meaning no isolated body parts, no headless bodies, no stereotype scenes

Alongside those come the policy recommendations from ten guideline papers and seven reviews. One of them is new for the German-speaking record: discrimination on the basis of body weight should be formally recognised as a legitimate social concern and written into anti-discrimination law, which already prohibits discrimination on other personal characteristics.

We know that demand. We described it in our piece on Germany’s federal anti-discrimination survey, where it comes from an advocacy association and from the researchers commissioned by the government agency. What is new is who else is making it now: a state-backed HTA agency, in an evidence report, addressed to decision-makers inside the health system.

The point

And here is the sentence the whole debate hangs on. The report’s conclusion states that interventions for children and adolescents, and structural measures, were not examined in any of the identified studies. The discussion says it again at greater length: the effectiveness of recommended strategies such as communication-based interventions, changes to the environment, and patient empowerment strategies has not yet been studied.

There is not one effectiveness study on whether a waiting room with chairs that fit and a scale with an adequate range changes anything about care. Not because it was tested and failed. Because nobody tested it.

The training debate is loud because training is the only thing that gets evaluated regularly. It is cheap to demand, easy to measure, it produces certificates of attendance, and it leaves nobody with an invoice for new examination tables. The measures you could verify in an afternoon, by walking into a waiting room and looking at a scale, have no evidence base because they were never made a research subject.

That is not a defence of training and not proof for equipment. It is a statement about what has been considered worth measuring for the past decade.

Placing the source

AIHTA is part of the health system and argues from inside its frame. The report treats overweight and obesity as medical categories, lists treatment recommendations, and draws in part on guidelines from professional societies with an interest in treatment. Readers should know that.

What it recommends is nonetheless notable. The Health at Every Size model is named repeatedly as a central approach, on the grounds that it places the focus on health and wellbeing rather than weight reduction. Re-evaluating interventions and guidelines built on a weight-centred approach, meaning BMI as an indicator of health, also appears as a recommendation. That is not a position one expects from an HTA agency.

External review was carried out by Friedrich Schorb of the University of Bremen and Martina Hermann-Thurner of Austria. The report states explicitly that the external reviewers are not co-authors and do not necessarily agree with its content. The authors declare no conflicts of interest.

One small internal inconsistency, for completeness: the results section lists twelve instruments for explicit and two for implicit weight bias, the discussion section says ten and one. It does not change the order of magnitude.

What follows

Anyone in Germany or Austria who wants to do something about weight stigma in healthcare has, after these two documents, two options. The first is well studied and works in a limited, short-term way on what people say. The second has not been studied at all, but can be checked without a study.

We will keep citing both sources. Neither one as evidence that training works or does not.

---

Sources

• Wolf, S. and Kern, J.: Strategien zur Reduktion von Gewichtsstigmatisierung bei Personen mit Übergewicht oder Adipositas im Gesundheitswesen. AIHTA Project Report No. 160, Vienna, November 2024. Full text: https://eprints.aihta.at/1547/
• Jayawickrama, R. S. et al.: Interventions to reduce weight stigma in healthcare students. Obesity Reviews 26(2):e13847, online 8 October 2024. DOI 10.1111/obr.13847

Image: original editorial graphic.

Germany runs a tidy little argumentative loop, and it has been spinning for almost twenty years.

The General Equal Treatment Act, the AGG, names six protected characteristics: sex, ethnic origin, religion or belief, disability, age, sexual identity. Body weight is not one of them. Because it is not in the law, the large government-commissioned surveys do not ask about it. Because they do not ask, there is no solid data. And because there is no solid data, the argument for adding the characteristic to the law is missing.

The loop stalled once. In the largest discrimination survey ever conducted in Germany, weight showed up even though nobody had asked about it. The researchers ended up recommending that the law be widened. Nothing has happened since.

What the study is

The Federal Anti-Discrimination Agency commissioned the study “Diskriminierungserfahrungen in Deutschland” from the Berlin Institute for Empirical Integration and Migration Research (BIM) at Humboldt University. The authors are Steffen Beigang, Karolina Fetz, Dorina Kalkum and Magdalena Otto. Fieldwork ran in autumn 2015; the 340-page results report appeared in 2017.

The study has two parts, and the distinction matters:

• a telephone representative survey with 1,007 participants,
• a survey of affected people in mixed-mode design with 18,162 participants (16,798 online, 1,364 on paper), open to anyone living in Germany aged 14 and over.

The second is the largest of its kind in Germany, with 14,765 usable first-hand accounts of discrimination. It is not representative, and it was never meant to be. People opted in themselves. Respondents could describe up to two experiences from the previous 24 months that mattered most to them.

The preset characteristics were the six AGG categories plus social position. Anyone whose experience fit none of those boxes had to write it into a free-text field and name it themselves.

How weight got into the study anyway

That free-text field is where advocacy groups went to work. In autumn 2015 the Gesellschaft gegen Gewichtsdiskriminierung (Society Against Weight Discrimination) called on people to take part under the slogan “Deine Stimme hat Gewicht” and pointed explicitly at the free-text field. It was not the only organisation doing this.

That belongs on the table, because it shapes the numbers that came out. And it is not an outside accusation: the research team says so in the report itself. The varying frequencies of characteristics may “also reflect how strongly particular associations promoted the survey”. The absolute figures, the report says, serve “expressly only to present the data basis” and must not be read as a statement about which kind of discrimination happens most often.

Christine Lüders, then head of the Anti-Discrimination Agency, framed it the same way in an interview: the number of accounts is “first of all not an indication of how frequently these things occur, only that these experiences exist”.

That is the honest version. It makes a worse headline than “this many cases”, and it is the only one that holds.

The number, and the two other numbers

Table 9 of the report, page 128, lists appearance with 935 reported cases. Indented underneath it, as a sub-category: weight, 634. That is the figure that has circulated since 2017, and it is correct.

Two variants float around next to it.

643 appears in a single secondary account; two sentences later the same text says 634 again. A transposition error.

534 appears in a specialist article by the research team itself. In 2017, Beigang, Otto, Fetz and Kalkum re-analysed the data for exactly this question in the series “Wissen schafft Demokratie” published by the Institute for Democracy and Civil Society (DOI 10.19222/201702/6). There the count is 534 cases of weight discrimination and 558 cases of discrimination based on a physical impairment, 1,092 cases in the analysis.

The gap between 634 and 534 is not a contradiction but a different base population. The online appendix states the selection rule: cases naming both weight and a physical impairment were excluded, as were cases where neither characteristic was clearly identified. How many cases fall under which exclusion is not published. So the difference of a hundred cases can be explained, but not recalculated.

Where these cases come from: the doctor’s office

The raw count is the least interesting part of the finding. What matters is where the cases cluster, and for that the research team built its own measure: the transfer factor. It compares how many reports for a characteristic actually come from a given area of life with how many would be expected if all characteristics were spread evenly across all areas. A value of 1 means as expected. A value of 2 means twice as often as expected.

For weight in the health and care sector, Table 29 on page 230 reports:

• Doctor’s practice, psychotherapy and similar: 5.95 (114 cases)
• Hospital: 2.27 (25 cases)
• Health, long-term care or pension insurance: 2.11 (17 cases)
• Social services: 0.93 (2 cases), other: 0.26 (1 case)

In medical practices, in other words, weight discrimination is reported almost six times as often as the distribution would lead you to expect. That is higher than the value for appearance overall (4.32) and higher than every other characteristic in that column. For comparison: disability, impairment and chronic illness come in at 1.65 there, being trans at 2.45.

This holds inside a non-representative sample. It does not tell you how many fat people in Germany are discriminated against at the doctor’s. It tells you where the experiences of those who did report concentrate, and that is unambiguous: not at work, not at the public authority, but at the doctor’s. What to do in that situation is something we have written up separately.

A second finding from the same report fits. Where discrimination is co-caused by the physical setting, meaning a lack of accessibility, 31.1 per cent of all such cases in the health and care sector are linked to weight. Examination tables, chairs and equipment are frequently not built for people at higher weights.

What else holds up in this data

The second solid piece is a comparison inside the same dataset. The research team set weight discrimination against discrimination based on a physical impairment. The choice is deliberate: both attach to the body, both accuse the person of deviating from bodily norms, both are experienced particularly often in the health system, and in both a lack of accessibility plays a large role. The decisive difference is legal. Disability is named in the constitution and in the AGG. Weight is named nowhere.

The results:

• Took no action at all against the person or condition causing it: 37.8 per cent of those affected in the impairment group, but 65.7 per cent in the weight group. Two out of three.
• Sought counselling afterwards: 17.0 per cent in the impairment group, 4.9 per cent in the weight group.

The obvious objection is that this might be down to different circumstances, different areas of life, different age groups, different forms of discrimination. The team tested that objection in multivariate regressions, N = 1,092. For four of the reasons given for doing nothing, the difference survives controls for situation and person: the expectation that reacting would achieve nothing, the burden of having to deal with it further, not seeing a need to react, and not knowing what could be done.

For two other reasons, fear of negative consequences and fear of not being believed, the difference disappears once situation and person are controlled for. That belongs in the picture too. The team limited its own finding here rather than pushing it through.

The models explicitly explain only a small share of the variance; the team puts the adjusted R² at 0.04 to 0.15 and writes that important explanatory variables are missing. So the finding is not: we know why fat people do not fight back. It is: the fact that they do it less often is not because different things happen to them.

The loop, said out loud

The four reasons that survive describe precisely what a missing law does.

“It wouldn’t achieve anything” is not resignation when there is no legal protection; it is an accurate reading of the situation. “I didn’t know what to do” is not an information deficit on the part of those affected; it describes a counselling system built along the AGG characteristics, which has little to offer for a characteristic that does not appear there. And “I saw no need to act” is the most uncomfortable point: when a society treats high body weight as self-inflicted, people affected partly adopt that attribution and consider the disadvantage understandable. Citing qualitative interviews, the research team calls this “solidarity with those doing the discriminating”.

The recommendation that followed was in the report back in 2017, on page 97, and it came from the researchers, not from an advocacy group:

The many experiences of discrimination that people have had on the basis of external characteristics, and in particular on the basis of weight, demonstrate the urgent need to create a way for these people to defend themselves against their experiences of discrimination. In order to offer these people protection against discrimination as well, the characteristics protected in the AGG should be extended to include external characteristics.

The team also proposed turning the AGG’s list of characteristics from a closed list into an open one, so that courts could recognise comparable characteristics that are not explicitly named.

Nothing has happened since. The AGG still does not know body weight. Legal protection exists only by detour: someone whose obesity requires medical treatment because of accompanying or consequent illness may under some circumstances be protected via the characteristic of disability. That construction goes back to a 2014 ruling of the European Court of Justice (FOA v Kommunernes Landsforening). It means protection exists if you are ill enough. Being fat alone does not get you there. The same pattern shows up in coverage decisions for weight-loss drugs, where France pays and Germany does not.

What this means for readers

First: if you experienced disadvantage because of your weight and had the impression that no office was responsible, you did not imagine it. That is the documented state of affairs, not a personal failure. And you are not alone in it; we have described where fat people in Germany meet offline.

Second: the organisation working on exactly this legal question in Germany is the Gesellschaft gegen Gewichtsdiskriminierung. It demands that “body weight” be added to § 1 AGG, that the membership threshold for anti-discrimination associations under § 23 AGG be lowered, and that the advisory board of the Anti-Discrimination Agency be expanded by a 17th seat. Two things belong disclosed alongside that. In the Bundestag lobby register (R007584), the organisation has been listed as a former interest representative since 24 October 2025, so its active registration has ended. And for financial year 2023 it reports project funding from the Anti-Discrimination Agency of 70,001 to 80,000 euros, for developing training that qualifies anti-discrimination counselling centres on weight discrimination. The same agency whose study never asked about the characteristic is funding the training on it.

Third, and this is the unsatisfying part: as long as the characteristic is missing, the route via existing characteristics remains the only legally solid one, and it fits only in exceptional cases. We will expand on that in a separate piece once the legal position has been worked through properly.

Transparency about this research

Every figure from the results report used here comes from the report itself (340 pages, checked 19 August 2026): the 634 from Table 9 on page 128, the transfer factors from Table 29 on page 230, the recommendation from page 97, the method behind the transfer factor from page 129. The response data (65.7 versus 37.8 per cent, 4.9 versus 17.0 per cent) and the regressions come from the research team’s specialist article and its online appendix, not from the results report.

One trap belongs on the record: the official summary of the study contains a different five-fold figure, namely that women report sex-based discrimination almost five times as often as men. That has nothing to do with weight. Pulling the two together produces a false statement.

Sources

• Federal Anti-Discrimination Agency: Diskriminierungserfahrungen in Deutschland. Ergebnisse der Repräsentativ- und der Betroffenenbefragung. Beigang/Fetz/Kalkum/Otto, 2017. https://www.antidiskriminierungsstelle.de/SharedDocs/downloads/DE/publikationen/Expertisen/expertise_diskriminierungserfahrungen_in_deutschland.html
• Beigang/Otto/Fetz/Kalkum: Eine Frage von Gewicht. Wissen schafft Demokratie 2/2017, IDZ Jena, DOI 10.19222/201702/6. https://www.idz-jena.de/wsddet/wsd2-6
• Online appendix to Beigang et al. 2017 (case selection, operationalisation, regression tables). https://www.idz-jena.de/fileadmin/user_upload/Anhang_Beigang_et_al_5.pdf
• Bundestag lobby register, entry R007584 (Gesellschaft gegen Gewichtsdiskriminierung e. V.). https://www.lobbyregister.bundestag.de/suche/R007584
• Gesellschaft gegen Gewichtsdiskriminierung e. V., collected posts on the Anti-Discrimination Agency. https://gewichtsdiskriminierung.de/tag/ads/
• Gesellschaft gegen Gewichtsdiskriminierung e. V., interview with Christine Lüders. https://gewichtsdiskriminierung.de/gewichtsdiskriminierung-eine-alltaegliche-erfahrung-in-deutschland/